SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

Tilray is trending as traders speculate on potential near-term catalysts related to cannabis rescheduling following comments from a key political figure. The community is closely watching for further developments, with some expecting a possible short squeeze and others debating the long-term fundamentals of the stock. Broader discussions include the potential impact on the cannabis industry, particularly for veterans and medical research.

AMC Robotics Corp. engages in developing and deploying AI-enabled robotics and smart security solutions, especially for warehouse automation, enterprise security, robotics patrol/incident-response and logistics automation. The company is headquartered in New York, NY.

AMC Robotics Corp.

AMCI is trending due to its recent surge, driven by excitement around its merger and potential in the robotics sector. Community members are actively discussing potential squeezes and price targets, while acknowledging the stock's volatility and low float. Bullish sentiment seems strong, with many hoping it can continue its momentum.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizer is trending as investors digest the company's weaker-than-expected 2026 outlook, particularly concerning COVID-19 drug demand and patent expirations. The community is actively discussing the potential for dividend cuts and the need for a new growth engine beyond COVID-related revenue. Some investors are taking a long-term view, focusing on the dividend yield and potential upside from the company's pipeline.

B. Riley Financial, Inc. engages in the provision of financial services and solutions to the capital raising and financial advisory needs of public and private firms. It operates through the following segments: Capital Markets, Wealth Management, Financial Consulting, Auction and Liquidation, Communications, and Consumer. The Capital Markets segment provides investment banking, corporate finance, research, wealth management, and sales and trading services to corporate, institutional, and high net worth clients. The Wealth Management segment offers retail brokerage, investment management, and insurance, and tax preparation services. The Financial Consulting segment focuses on a variety of specialized advisory services spanning bankruptcy, restructuring, turnaround management, forensic accounting, crisis and litigation support, appraisal and valuation, real estate, and operations management. The Auction and Liquidation segment deals with retail liquidation services. The Communications segment is composed of a portfolio of companies acquired for attractive risk-adjusted investment return characteristics. The Consumer segment includes Targus and the Brands investment portfolio. The company was founded in 1973 and is headquartered in Los Angeles, CA.

B. Riley Financial Inc

B. Riley Financial is trending due to a swing to profitability revealed in their Q2 earnings filing, which has sparked a surge in intraday trading. The community is discussing the potential for a turnaround squeeze, citing high short interest and a low float, drawing parallels to CVNA's past performance. Positive catalysts and debt restructuring are also key talking points.

Aldeyra Therapeutics, Inc. is a biotechnology company, which engages in research and development activities with related general business planning, including raising capital. It engages in the discovery of therapies designed to treat immune-mediated diseases. The company was founded by Thomas A. Jordan and John E. Dowling on August 13, 2004 and is headquartered in Lexington, MA.

Aldeyra Therapeutics Inc

ALDX is trending due to anticipation surrounding its upcoming FDA decision on its dry eye drug, reproxalap, with the community actively debating the likelihood of approval after previous setbacks. Discussions also involve the potential impact of a new RASP pipeline focus and a collaboration with AbbVie. Community members are weighing the potential for a short squeeze and a significant price movement based on the FDA's verdict.

Affirm Holdings, Inc. operates a platform for digital and mobile-first commerce. Its platform consists of three core elements: a point-of-sale payment solution for consumers, merchant commerce solutions, and a consumer-focused app. The company was founded by Max R. Levchin in 2012 and is headquartered in San Francisco, CA.

Affirm Holdings Inc - Ordinary Shares - Class A

Affirm Holdings Inc

Affirm is trending amid anticipation for upcoming earnings, with analysts projecting significant EPS growth. Community discussions include speculation on the potential impact of consumer credit trends and the company's valuation. The stock is exhibiting volatility, influenced by broader market sentiment and sector-specific news.

The 401jk (just kidding) meme is a satirical punch in the gut in the face of the concept of retirement and also the 401k. The 401k total holdings are valued at around $12 trillion USD and it is the most popular retirement savings plan in the US. As time passes forevermore true retirement, or as we like to call it real freedom will only become much harder and harder for people to attain.  Through meme fueled laser focus and cyperphunk ideology the 401jK meme retirement fund token and community aim to point out the absurdities of how rigged our current system is, and how only insiders and those with power are starting the benefit from the increased centralization of cryptocurrency.........while also aiming to flip the $12 trillion USD 401k system to achieve freedom before our backs and knees are breaking.

401jK

401JK is trending as the community rallies around the launch of staking, with users excitedly reporting significant amounts already staked. The coin's narrative, centered on challenging traditional retirement systems, resonates with many who see it as a movement. Community members highlight the project's strong holder base and meme-driven approach.

Luckin Coffee, Inc. engages in providing food and beverage items, and operates coffee retail stores. It has a pioneered a technology-driven retail network to provide coffee and other products of high quality, high convenience and high affordability to customers. The company manages pick-up stores, relax stores, and delivery kitchens. It also offers tea, snacks, and light meals through its mobile application. The company was founded by Zhi Ya Qian, Fei Yang and Jin Yi Guo on June 16, 2017 and is headquartered in Xiamen, China.

Luckin Coffee Inc - ADR

LKNCY is trending as investors discuss the recent price drop and potential reasons behind it, including lack of liquidity, possible selling by large shareholders, and concerns about transparency. The community is actively debating whether the drop presents a buying opportunity or signals deeper issues with the company, while also speculating on the potential for relisting and acquisitions.

Biodexa Pharmaceuticals Plc is a drug delivery technology company. It is focused on the research and development of medicines for rare cancers, via both in-house programs as well as partnered programs. The firm's proprietary platform drug delivery technologies are Q-Sphera platform is a disruptive polymer microsphere technology, which is used for sustained release at the microscale to prolong and control the release of therapeutics over an extended period of time from weeks to months; Midasolve platform is an innovative nano saccharide technology, which is used to dissolve drugs at the nanoscale so that they can be administered in liquid form directly and locally into tumors; Midacore platform is an edge gold nanoparticle technology, which is used for targeting sites of disease at the nanoscale. The company was founded in 2000 and is headquartered in Cardiff, the United Kingdom.

Biodexa Pharmaceuticals Plc - ADR

Biodexa Pharmaceuticals Plc

Biodexa Pharmaceuticals is trending due to recent price volatility and community speculation about potential catalysts. Discussions revolve around its low float and potential for a short squeeze, with some eyeing it as a potential high-reward play. The stock's movements are also being compared to other recent high-flying low float stocks.

Reddit, Inc. operates an entertainment, social networking, and news website where registered community members can submit content. It provides online news services where users can select and rank web content. The firm also offers a personalized filter on the day's story, using previous votes to determine what new things the user might like to read. The company was founded by Steven Ladd Huffman and Alexis Ohanian on June 23, 2005 and is headquartered in San Francisco, CA.

Reddit Inc. - Ordinary Shares - Class A

Reddit Inc

Reddit's potential for a short squeeze is a key focus, with high short interest and rising borrowing costs fueling speculation. Additionally, the community is discussing Reddit's growth prospects relative to other social media platforms, specifically highlighting new advertising tools and earnings momentum. Some investors are anticipating inclusion in the S&P 500 as a potential catalyst.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

The Geopolitical Windfall for Indian ETFs as Trump Hints at Tariff Cut 

Indian ETFs like INDA and FLIN gain spotlight as U.S.-India trade deal seems to near, which could slash tariffs and reignite investor confidence. 

Decent Growth Vs. Tariff Fears: What Lies Ahead of India ETFs?

India's economy grew at an annual rate of 7.8% in the quarter ending June, topping economists' expectations of 6.7% (Reuters poll), as quoted on CNBC.

Shares of MakeMyTrip ($MMYT) jumped 6% on Thursday as the online travel company reported strong revenue jump for its third-quarter earnings compared to last year but missed earnings estimates, with retail sentiment staying bearish.MakeMyTrip posted diluted earnings per share of $0.23, below the consensus estimate that Wall Street analysts expected at $0.27, according to Stocktwits data.&nbsp;However, Its revenues stood at $267.4 million, jumping 24.8% year-over-year, beating consensus estimates of $268.1 million.The increase in revenue was primarily due to strong travel demand in India for both domestic and international outbound travel in the quarter, the company said. The revenue increase was led by its hotels and packages business which saw an increase of 23.4% over the last quarter to $121.9 million.As at December 31, the company's cash and cash equivalents and term deposits stood at $705.5 million.“The Indian travel and tourism sector is witnessing robust growth, reflecting a strong desire among travelers to explore new horizons. While Indian destinations continue to shine, many countries have made significant efforts to attract Indian travelers. Our strong performance this quarter reflects these macro trends, along with our focused execution and commitment to customer centricity," Rajesh Magow, Group CEO said.Sentiment on Stocktwits inched up to 'bearish' from 'extremely bearish.' Message volumes were in the 'high' zone compared to 'extremely high' a day ago.<figure class="image"><img style="aspect-ratio:1292/308;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2025_01_24_at_8_49_50_AM_778ce36030.png" alt="Screenshot 2025-01-24 at 8.49.50 AM.png" width="1292" height="308"><figcaption>MakeMyTrip sentiment meter and message volumes on Jan 23 as of 10:40 pm ET</figcaption></figure>To be sure, some commenters on the Stocktwits platform were still bullish.<stembedurl>https://stocktwits.com/NotaTraitor/message/601144059</stembedurl>MakeMyTrip offers air ticketing, hotels and packages, and rail tickets, among other ancillary travel services. &nbsp;MakeMyTrip stock is down 2.53% year-to-date.For updates and corrections, email newsroom[at]stocktwits[dot]com

Representative image. Source: Getty Images

MakeMyTrip Stock Surges After Q3 Revenue Jump: Retail's Not Convinced

Its revenues stood at $267.4 million, jumping 24.8% year-over-year, beating consensus estimates

Equity

Shares of MakeMyTrip ($MMYT) have fallen about 2% in the past five days ahead of the online travel company’s third-quarter earnings, dampening retail sentiment.MakeMyTrip will report its financial and operating results before the bell on Thursday, January 23.Wall Street analysts expect $0.27 in earnings per share on estimated revenues of $264.99 million, according to Stocktwits data. The full year 2025's EPS is expected to be about $1.04 per share on revenue of $989.86 million.For the second quarter, MakeMyTrip reported $210.99 million in revenues, missing analyst expectations. Its EPS stood at $0.16, also falling short of estimates of $0.18.Sentiment on Stocktwits was in the ‘extremely bearish’ zone compared to last week. Message volumes have increased to ‘extremely high’ from ‘high.’ <img src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2025_01_23_at_7_03_01_AM_e22d3a31b6.png" alt="Screenshot 2025-01-23 at 7.03.01 AM.png"> However, BofA analyst Sachin Salgaonkar took a more positive view on the stock, raising the firm's price target to $130 from $119 with a ‘Buy’ rating, Fly.com reported.According to the analyst, normal strong seasonality trends have been in play in the third quarter for the industry and MakeMyTrip is expected to report "a strong set of numbers in the seasonally strong" quarter, added the report.MakeMyTrip offers air ticketing, hotels and packages, and rail tickets, among other ancillary travel services. &nbsp;MakeMyTrip stock is down 8% year-to-date.For updates and corrections, email newsroom[at]stocktwits[dot]com

MakeMyTrip Stock In Focus Ahead of Q3 Earnings: Retail’s Downbeat

Sentiment on Stocktwits was in the ‘extremely bearish’ zone compared to last week.

Shares of MakeMyTrip ($MMYT) were in the spotlight on Friday morning after the company received a price target revision from Bofa Securities on the back of growing travel demand. However, retail sentiment remained ‘neutral.’Bofa analyst Sachin Salgaonkar raised the price target for MakeMyTrip from $119.00 to $130.00 with a ‘Buy’ rating, The Fly.com reported. The analyst reportedly has a positive outlook on the company's earnings potential and market position in the travel industry. Specifically, the roll forward of the company's discounted cash flow (DCF) analysis prompted the hike, Investing.com <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.investing.com/news/analyst-ratings/bofa-maintains-buy-on-makemytrip-stock-despite-minor-eps-impact-from-inr-weakness-93CH-3789828">reported.</a>The company’s recent $150 million share buyback program also serves as a safety net for the stock price and offers support to the company’s market valuation.MakeMyTrip stock has risen 2.32% in the past five days and is up 153% year-to-date.Retail sentiment on Stocktwits was ‘neutral’ with message volumes leaning high, showing increased investor attention on the stock.<figure class="image"><img style="aspect-ratio:1256/302;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_12_27_at_7_27_37_PM_8c1788e1d5.png" alt="Screenshot 2024-12-27 at 7.27.37 PM.png" width="1256" height="302"><figcaption>MMYT sentiment meter and message volumes on Dec 27th as of 9:15 am ET</figcaption></figure>Several commenters on Stocktwits, however, were bullish on the overall prospects for travel stocks.<stembedurl>https://stocktwits.com/MaverikIT/message/597866494</stembedurl><stembedurl>https://stocktwits.com/MaverikIT/message/597653965</stembedurl><stembedurl>https://stocktwits.com/AskLou/message/597468745</stembedurl>MakeMyTrip offers air ticketing, hotels and packages, and rail tickets, among other ancillary travel services. &nbsp;The company is expected to report third-quarter earnings in January. Wall Street analysts expect $0.27 in earnings per share on estimated revenues of $264.99 million.For updates and corrections, email newsroom[at]stocktwits[dot]com.

MakeMyTrip Stock In Spotlight After BofA’s Price Target Revision: But Retail's Neutral

MakeMyTrip stock has risen 2.32% in the past five days.

Exchange Traded Concepts Trust - India Internet & Ecommerce ETF

Up more than 2%

Up 0–2%

Flat to down 2%

Down more than 2%

The S&P 500 is modestly lower so far in December, putting the Santa Claus rally in question. The Santa Claus rally refers to the market’s tendency to rise in the final weeks of the year—what do you expect from December 16 through December 31?

What do you expect the S&amp;P 500’s total return to be in the second half of December?

Stocktwits

What do you expect the S&P 500’s total return to be in the second half of December?

INQQ
Exchange Traded Concepts Trust - India Internet & Ecommerce ETF

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest INQQ News

INQQExchange Traded Concepts Trust - India Internet & Ecommerce ETF